- Home
- MNOV vs ASRT Comparison
MNOV vs ASRT Comparison
Compare MNOV & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- ASRT
- Stock Information
- Founded
- MNOV 2000
- ASRT 1995
- Country
- MNOV United States
- ASRT United States
- Employees
- MNOV N/A
- ASRT N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- MNOV Health Care
- ASRT Health Care
- Exchange
- MNOV Nasdaq
- ASRT Nasdaq
- Market Cap
- MNOV 76.0M
- ASRT 65.7M
- IPO Year
- MNOV 2005
- ASRT 1997
- Fundamental
- Price
- MNOV $1.56
- ASRT $0.62
- Analyst Decision
- MNOV Strong Buy
- ASRT Strong Buy
- Analyst Count
- MNOV 1
- ASRT 3
- Target Price
- MNOV $9.00
- ASRT $3.08
- AVG Volume (30 Days)
- MNOV 16.0K
- ASRT 420.6K
- Earning Date
- MNOV 05-08-2025
- ASRT 05-05-2025
- Dividend Yield
- MNOV N/A
- ASRT N/A
- EPS Growth
- MNOV N/A
- ASRT N/A
- EPS
- MNOV N/A
- ASRT N/A
- Revenue
- MNOV N/A
- ASRT $124,961,000.00
- Revenue This Year
- MNOV N/A
- ASRT N/A
- Revenue Next Year
- MNOV N/A
- ASRT $11.20
- P/E Ratio
- MNOV N/A
- ASRT N/A
- Revenue Growth
- MNOV N/A
- ASRT N/A
- 52 Week Low
- MNOV $1.12
- ASRT $0.51
- 52 Week High
- MNOV $2.55
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- MNOV 60.40
- ASRT 43.68
- Support Level
- MNOV $1.43
- ASRT $0.57
- Resistance Level
- MNOV $1.52
- ASRT $0.80
- Average True Range (ATR)
- MNOV 0.09
- ASRT 0.05
- MACD
- MNOV 0.03
- ASRT 0.01
- Stochastic Oscillator
- MNOV 100.00
- ASRT 77.14
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.